Loading
Pneumonia and Respiratory Infections · Journal article
Microbiology Spectrum · July 13, 2026
Raises a question worth testing. It does not answer one.
This is a mechanistic CRISPR interference study that identifies functional redundancy among mycobacterial respiratory enzymes and maps synthetic lethal interactions, notably between cytochrome bcc-aa3 (qcrB) and malate-quinone oxidoreductase (mqo). The work is exploratory and does not test inhibitor compounds, demonstrate drug efficacy, or establish clinical utility.
Uncontrolled mechanistic study using CRISPR interference. Mycobacterium tuberculosis. Intervention: CRISPRi-mediated transcriptional knockdown of respiratory chain genes (including qcrB and mqo).
Functional redundancy identified between homologous groups of respiratory enzymes Synthetic lethal interaction demonstrated between cytochrome bcc-aa3 (qcrB) and malate-quinone oxidoreductase (mqo) Network of lethal interactions identified across single, double, triple, and quadruple gene knockdowns
Transcriptional knockdown via CRISPRi does not confirm that pharmacological inhibitors of the same targets will produce identical or lethal phenotypes
This identifies potential combination targets for future drug development against drug-resistant M. tuberculosis, but does not yet provide evidence that inhibitors of these targets are safe or effective in patients.
CRISPR interference study identifying synthetic lethal interactions in mycobacterial respiratory complexes; mechanistic, uncontrolled, and does not yet demonstrate drug efficacy or clinical relevance.
As stated by the source record.
This identifies potential combination targets for future drug development against drug-resistant M. tuberculosis, but does not yet provide evidence that inhibitors of these targets are safe or effective in patients.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
ABSTRACT There is an urgent need for novel drug targets and combination therapies for Mycobacterium tuberculosis. The identification of inhibitors that target the mycobacterial respiratory chain, particularly when used in combination, has emerged as an exciting new avenue for addressing antibiotic resistance. However, the lack of inhibitors for respiratory complexes, possible functional redundancy between homologous enzymes, and a poor knowledge of which complexes, when simultaneously inhibited, have lethal phenotypes, have slowed progress in this space. To address these limitations, we have utilized CRISPR interference (CRISPRi) to identify bioenergetic complexes that are functionally redundant or that, when simultaneously inhibited, lead to cell death. Specifically, single, double, triple, and quadruple gene knockdowns of respiratory chain components were developed to investigate the consequences of transcriptional inhibition on cell viability. In addition to functional redundancy being identified between homologous groups of respiratory enzymes, we identify a network of synthetic lethal interactions, including the demonstration of a synthetic lethal interaction between the terminal oxidase cytochrome bcc - aa 3 (i.e., qcrB ) and malate-quinone oxidoreductase ( mqo ). In conclusion, these findings reinforce that interactions between bioenergetic complexes are crucial to the growth of M. tuberculosis and represent promising targets for future combination therapies. IMPORTANCE New drugs and combination therapies are urgently needed to treat infections caused by Mycobacterium tuberculosis. Drugs that target the mycobacterial respiratory chain, particularly when used in combination, have emerged as an exciting new avenue for addressing antibiotic resistance. However, functional redundancy between respiratory enzymes and a poor knowledge of which respiratory complexes are simultaneously inhibited have lethal phenotypes, which have slowed the development of drugs in this field. To address these limitations, we have utilized CRISPR interference (CRISPRi) transcriptional knockdowns to identify respiratory complexes that are functionally redundant or that, when simultaneously inhibited, lead to cell death. This work demonstrates that (i) there is functional redundancy between functionally similar respiratory enzymes and (ii) there is a network of lethal interactions. These findings reinforce that interactions between bioenergetic complexes are crucial to the growth of M. tuberculosis and represent promising targets for future combination therapies.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.